TEHRAN – Iranian basketball player Mehdi Jafari has been banned for two-year for using Ephedrine.
Jafari will be ineligible from May 29, 2022 until May 28, 2024.
The accusation has been confirmed by the anti-doping laboratory in Cologne and WADA.
Ephedrine is a medication used in the management and treatment of clinically significant hypotension.
It is in the sympathomimetic class of medications. This activity illustrates the indications, action, and contraindications for ephedrine as a valuable agent in the treatment of clinically significant hypotension.
Original News : https://www.tehrantimes.com/news/475713/Iranian-basketballer-Jafari-banned-for-doping